SCHEMBL396013

SCHEMBL396013

[CH2]c1ccccc1CCCCCCCCCCCCCC

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LIPG Q9Y5X9 1/20 0.58
THRA P10827 1/20 0.47
THRB P10828 1/20 0.47
NR1H2 P55055 1/20 0.47
NR1H3 Q13133 1/20 0.47
BID P55957 3/20 0.45
MCL1 Q07820 3/20 0.45
BCL2L1 Q07817 2/20 0.45
BAK1 Q16611 2/20 0.45
KAT8 Q9H7Z6 2/20 0.45
PPARG P37231 1/20 0.45
PPARA Q07869 1/20 0.45
EP300 Q09472 1/20 0.45
KAT2A Q92830 1/20 0.45
KAT2B Q92831 1/20 0.45
KAT5 Q92993 1/20 0.45
SAE1 Q9UBE0 1/20 0.45
KCNH2 Q12809 2/20 0.44
ALOX5 P09917 2/20 0.43
PTGS2 P35354 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL375253 1.00 LIPG (0.58) LIPGTHRATHRBNR1H2NR1H3
SCHEMBL395649 1.00 LIPG (0.58) LIPGTHRATHRBNR1H2NR1H3
SCHEMBL10809003 1.00 LIPG (0.58) LIPGTHRATHRBNR1H2NR1H3
SCHEMBL5487867 1.00 LIPG (0.58) LIPGTHRATHRBNR1H2NR1H3
SCHEMBL19877232 1.00 LIPG (0.58) LIPGTHRATHRBNR1H2NR1H3
SCHEMBL139445 1.00 LIPG (0.58) LIPGTHRATHRBNR1H2NR1H3
SCHEMBL11369508 1.00 LIPG (0.58) LIPGTHRATHRBNR1H2NR1H3
SCHEMBL396330 1.00 LIPG (0.58) LIPGTHRATHRBNR1H2NR1H3
SCHEMBL7338375 1.00 LIPG (0.58) LIPGTHRATHRBNR1H2NR1H3
SCHEMBL7170683 1.00 LIPG (0.58) LIPGTHRATHRBNR1H2NR1H3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 273 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3904360-B1 NOVEL TETRAARYLBORATE COMPOUND, CATALYST COMPOSITION COMPRISING SAME, AND METHOD FOR PREPARING ETHYLENE HOMOPOLYMERS OR COPOLYMERS OF ETHYLENE AND ALPHA-OLEFIN BY USING SAME SABIC SK NEXLENE COMPANY PTE LTD (SG) 2024-07-03 EP disclosed
CN-113677686-B Novel tetraarylborate compounds, catalyst compositions comprising the same, and process for preparing ethylene homopolymers or copolymers of ethylene and alpha-olefins by using the same 沙特基础工业爱思开NEXLENE私人有限公司 2024-06-11 CN disclosed
CN-117918376-A Salt-resistant povidone iodine concentrated solution and preparation method thereof 成都科宏达科技有限公司 2024-04-26 CN disclosed
CN-111148748-B Novel indene-based transition metal compound, transition metal catalyst composition comprising the same, and method for preparing ethylene homopolymer or copolymer of ethylene and alpha-olefin by using the same 沙特基础工业爱思开NEXLENE私人有限公司 2023-05-16 CN disclosed
CN-113677686-A Novel tetraarylborate compound, catalyst composition comprising the same, and method for preparing ethylene homopolymer or copolymer of ethylene and alpha-olefin by using the same 沙特基础工业爱思开NEXLENE私人有限公司 2021-11-19 CN disclosed
EP-3904360-A1 NOVEL TETRAARYLBORATE COMPOUND, CATALYST COMPOSITION COMPRISING SAME, AND METHOD FOR PREPARING ETHYLENE HOMOPOLYMERS OR COPOLYMERS OF ETHYLENE AND ALPHA-OLEFIN BY USING SAME SABIC SK Nexlene Company Pte. Ltd. (SG) 2021-11-03 EP disclosed
US-10919992-B2 Indene-based transition metal compound, transition metal catalyst composition comprising same, and method for preparing ethylene homopolymer or copolymer of ethylene and alpha-olefin by using same SABIC SK NEXLENE COMPANY PTE. LTD. (SG) 2021-02-16 US disclosed
US-20200262943-A1 NOVEL INDENE-BASED TRANSITION METAL COMPOUND, TRANSITION METAL CATALYST COMPOSITION COMPRISING SAME, AND METHOD FOR PREPARING ETHYLENE HOMOPOLYMER OR COPOLYMER OF ETHYLENE AND ALPHA-OLEFIN BY USING SAME SABIC SK NEXLENE COMPANY PTE. LTD. (SG) 2020-08-20 US disclosed
EP-3689884-A1 NOVEL INDENE-BASED TRANSITION METAL COMPOUND, TRANSITION METAL CATALYST COMPOSITION COMPRISING SAME, AND METHOD FOR PREPARING ETHYLENE HOMOPOLYMER OR COPOLYMER OF ETHYLENE AND -OLEFIN BY USING SAME Sabic Sk Nexlene Company Pte. Ltd. (SG) 2020-08-05 EP disclosed
CN-111148748-A Novel indene-based transition metal compound, transition metal catalyst composition comprising the same, and method for preparing ethylene homopolymer or copolymer of ethylene and α -olefin by using the same 沙特基础工业爱思开NEXLENE私人有限公司 2020-05-12 CN disclosed
EP-0702517-A1 QUATERNARY AMMONIUM AND WATERPROOFING/PRESERVATIVE COMPOSITIONS LONZA INC. (US) 1996-03-27 EP disclosed
WO-1994028715-A1 QUATERNARY AMMONIUM AND WATERPROOFING/PRESERVATIVE COMPOSITIONS LONZA INC. (US) 1994-12-22 WO disclosed
EP-0108039-B1 AMMONIUM STANNATES-(IV) CIBA-GEIGY AG (CH) 1989-01-25 EP disclosed
EP-0109354-B1 BIOCIDALLY ACTIVE MIXTURE CIBA-GEIGY AG (CH) 1986-11-20 EP disclosed
US-4578489-A MICROBIOCIDES; WATER SOLUBILITY CIBA-GEIGY CORPORATION (US) 1986-03-25 US disclosed
US-4554367-A PRESERVATIVES, PLANT PROTECTIVE AGENTS CIGA-GEIGY CORPORATION (US) 1985-11-19 US disclosed
EP-0109354-A1 Biocidally active mixture CIBA-GEIGY AG (CH) 1984-05-23 EP disclosed
EP-0108039-A2 Ammonium stannates-(IV) CIBA-GEIGY AG (CH) 1984-05-09 EP disclosed
EP-0105843-A2 Phosphonium organohalostannates (IV) CIBA-GEIGY AG (CH) 1984-04-18 EP disclosed
US-4252565-A Stabilized phthalocyanines CIBA-GEIGY CORPORATION (US) 1981-02-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10919992-B2 Indene-based transition metal compound, transition metal catalyst composition comprising same, and method for preparing ethylene homopolymer or copolymer of ethylene and alpha-olefin by using same ETFB, EMC2, ICMT LIPG 3207/4885THRA 4069/4885THRB 4369/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.